BACKGROUND: Hemophilic arthropathy (HA) is a chronic joint disease caused by repeated joint bleeding in patients with hemophilia (PWH), leading to joint degeneration despite prophylactic treatment. The CX3CL1(fractalkine)-CX3CR1 chemokine axis regulates synovial lining macrophage function and has been implicated in inflammatory joint diseases including rheumatoid arthritis and osteoarthritis. OBJECTIVES: macrophages in experimental hemophilic arthropathy using genetic targeting and pharmacological inhibition. METHODS: knockout mice and the CX3CR1 non-competitive allosteric antagonist AZD8797. Outcomes were measured by changes in joint swelling after injury and histological assessment at Day 28 after injury for hemosiderin deposition and synovitis. RESULTS: mice. Similarly, treatment with a CX3CR1 antagonist did not attenuate the development of HA. CONCLUSIONS: macrophage recruitment during experimental HA, the CX3CL1-CX3CR1 axis is dispensable for the pathogenesis of acute hemophilic synovitis in this mouse model of severe hemophilia A.
Lawrence et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: